Composition and method for treating, relieving or preventing neuropathic pain, containing choline alfoscerate as active ingredient
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Apr 26, 2022
Grant Date -
Oct 29, 2020
app pub date -
Dec 10, 2018
filing date -
Dec 10, 2018
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Choline alfoscerate is useful for treating cognitive dysfunction associated with cerebrovascular diseases and degenerative brain diseases. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with neuropathic pain, it can significantly reduce the pain intensity and the occurrence of neuropathic pain. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing neuropathic pain and a health functional food composition for improving neuropathic pain and may also be used for a method for treating neuropathic pain by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating neuropathic pain.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully